Valuation: Abbott Laboratories

Market Cap 164B 143B 132B 122B 231B 15,604B 235B 1,577B 619B 7,687B 614B 601B 26,426B P/E 2026 *
23.2x
P/E 2027 * 19.8x
Enterprise Value 175B 153B 141B 131B 248B 16,719B 252B 1,690B 664B 8,236B 658B 644B 28,314B EV / Sales 2026 *
3.49x
EV / Sales 2027 * 3.15x
Free-Float
86.73%
Yield 2026 *
2.71%
Yield 2027 * 2.89%
1 day-0.50%
1 week-1.54%
Current month+3.52%
1 month+4.77%
3 months-6.35%
6 months-25.41%
Current year-25.03%
1 week 92.99
Extreme 92.99
98.14
1 month 87.21
Extreme 87.21
98.14
Current year 81.97
Extreme 81.97
129.46
1 year 81.97
Extreme 81.97
137.49
3 years 81.97
Extreme 81.97
141.23
5 years 81.97
Extreme 81.97
142.6
10 years 37.38
Extreme 37.38
142.6
Manager TitleAgeSince
Chief Executive Officer 52 2020-03-30
Director of Finance/CFO 53 2023-08-31
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 2011-12-08
Director/Board Member 67 2011-12-08
Director/Board Member 71 2017-02-15
Date Insider Type Main position Quantity % Market Cap.
Jun. 29Free

Director

432 0.0000%
Jun. 29Free

Director

231 0.0000%
Jun. 29Free

Director

363 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
-0.50%-1.54%-28.85%-12.62% 164B
+1.80%+0.82%-6.73%-3.92% 107B
+0.32%+2.34%+2.79%+57.04% 59.04B
+0.79%-3.68%+39.99%+54.50% 51.72B
+0.72%-3.88%-13.66%-41.41% 41.87B
+0.47%-4.98% - - 34.7B
+2.66%+5.21%-10.09%-42.88% 28.93B
-1.10%-3.29%+55.70%-5.76% 24.99B
0.00%-1.01%-5.28%-3.57% 21.05B
+2.06%+1.72%-10.01%-18.17% 20.39B
Average +0.72%-0.75%+2.65%-1.87% 55.37B
Weighted average by Cap. +0.56%-0.83%-5.77%+0.26%

Financials

2026 *2027 *
Net sales 50.26B 43.96B 40.55B 37.45B 71.06B 4,793B 72.25B 484B 190B 2,361B 189B 185B 8,117B 54.75B 47.89B 44.17B 40.8B 77.41B 5,222B 78.71B 528B 207B 2,572B 206B 201B 8,843B
Net income 7.02B 6.14B 5.66B 5.23B 9.92B 669B 10.09B 67.65B 26.57B 330B 26.35B 25.78B 1,134B 8.39B 7.34B 6.77B 6.25B 11.86B 800B 12.06B 80.87B 31.76B 394B 31.5B 30.81B 1,355B
Net Debt 11.69B 10.22B 9.43B 8.71B 16.53B 1,115B 16.81B 113B 44.25B 549B 43.89B 42.93B 1,888B 8.86B 7.75B 7.15B 6.6B 12.52B 845B 12.73B 85.38B 33.53B 416B 33.26B 32.53B 1,431B
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
115,000
Date Price Change Volume
26-07-10 $93.93 -0.50% 6,913,069
26-07-09 $94.40 -0.82% 8,357,750
26-07-08 $95.18 -0.69% 10,102,295
26-07-07 $95.84 +0.22% 10,262,177
26-07-06 $95.63 +0.24% 15,257,037
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
93.93USD
Average target price
116.40USD
Spread / Average Target
+23.92%

Quarterly revenue - Rate of surprise